240 related articles for article (PubMed ID: 27939191)
1. An elevated pro-inflammatory cytokines profile in Behcet's disease: A multiplex analysis.
Gholijani N; Ataollahi MR; Samiei A; Aflaki E; Shenavandeh S; Kamali-Sarvestani E
Immunol Lett; 2017 Jun; 186():46-51. PubMed ID: 27939191
[TBL] [Abstract][Full Text] [Related]
2. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
3. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
4. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease.
Touzot M; Cacoub P; Bodaghi B; Soumelis V; Saadoun D
Autoimmun Rev; 2015 May; 14(5):370-5. PubMed ID: 25541082
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
7. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
[TBL] [Abstract][Full Text] [Related]
8. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
Aktas Cetin E; Cosan F; Cefle A; Deniz G
Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
[TBL] [Abstract][Full Text] [Related]
9. Serum Th1, Th2 and Th17 cytokine profiles and alpha-enolase levels in recurrent aphthous stomatitis.
Ozyurt K; Celik A; Sayarlıoglu M; Colgecen E; Incı R; Karakas T; Kelles M; Cetin GY
J Oral Pathol Med; 2014 Oct; 43(9):691-5. PubMed ID: 24801453
[TBL] [Abstract][Full Text] [Related]
10. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
[TBL] [Abstract][Full Text] [Related]
12. Imbalance of Th17 to Th1 cells in Behçet's disease.
Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
[TBL] [Abstract][Full Text] [Related]
13. Role of IL-22- and TNF-α-producing Th22 cells in uveitis patients with Behcet's disease.
Sugita S; Kawazoe Y; Imai A; Kawaguchi T; Horie S; Keino H; Takahashi M; Mochizuki M
J Immunol; 2013 Jun; 190(11):5799-808. PubMed ID: 23630362
[TBL] [Abstract][Full Text] [Related]
14. Decreased B and T lymphocyte attenuator in Behcet's disease may trigger abnormal Th17 and Th1 immune responses.
Ye Z; Deng B; Wang C; Zhang D; Kijlstra A; Yang P
Sci Rep; 2016 Feb; 6():20401. PubMed ID: 26841832
[TBL] [Abstract][Full Text] [Related]
15. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells dominate a Th-1 polarized response in Behçet's disease patients with uveitis.
Kucuksezer UC; Aktas-Cetin E; Bilgic-Gazioglu S; Tugal-Tutkun I; Gül A; Deniz G
Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S24-9. PubMed ID: 25937098
[TBL] [Abstract][Full Text] [Related]
17. Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles.
Guimarães PM; Scavuzzi BM; Stadtlober NP; Franchi Santos LFDR; Lozovoy MAB; Iriyoda TMV; Costa NT; Reiche EMV; Maes M; Dichi I; Simão ANC
Immunol Cell Biol; 2017 Oct; 95(9):824-831. PubMed ID: 28649995
[TBL] [Abstract][Full Text] [Related]
18. Immune responses to interphotoreceptor retinoid-binding protein and S-antigen in Behcet's patients with uveitis.
Takeuchi M; Usui Y; Okunuki Y; Zhang L; Ma J; Yamakawa N; Hattori T; Kezuka T; Sakai J; Goto H
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3067-75. PubMed ID: 20089879
[TBL] [Abstract][Full Text] [Related]
19. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
Hamzaoui K; Hamzaoui A; Guemira F; Bessioud M; Hamza M; Ayed K
Scand J Rheumatol; 2002; 31(4):205-10. PubMed ID: 12369651
[TBL] [Abstract][Full Text] [Related]
20. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease.
Wu L; Wen H; Zhou Y; Yu H; Liu Y; Bai L; Kijlstra A; Yang P
Curr Mol Med; 2014; 14(6):712-22. PubMed ID: 25056541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
